FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200210965> ?p ?o ?g. }

• W4200210965 endingPage "45" @default.
• W4200210965 startingPage "37" @default.
• W4200210965 abstract "Introduction. Treatment and prevention of diseases of the oral mucosa is one of the priority tasks in dentistry. In practice, antibacterial agents are often used in the complex treatment of inflammatory and destructive processes. However, long-term, uncontrolled usage of such drugs leads to numerous complications: drug tolerance, weakening of the therapeutic effect, dysbiosis of the oral cavity and gastrointestinal tract, etc. Therefore, at present, the question of search for alternative to antibiotic therapy remains open. As an alternative, it is necessary considering the usage of effective and safe herbal medicines that are easy to digest, less toxic, practically do not cause side effects and allergic reactions, and have a light regulating and normalizing effect. Aim. The aim of the present study is to develop the composition and technology of effervescent granules for the preparation of a solution for rinsing the oral cavity based on phytosubstances. Materials and methods. Dry extracts were obtained from medicinal plant materials: medicinal sage leaves, medicinal calendula flowers, yarrow herb, medicinal rhizomes and roots and astragalus woolly herb. Sodium carbonate, citric acid, anhydrous, microcrystalline cellulose – 90 (EMCOCEL®90M), povidone (Plasdone™ K-29/32) and calcium stearate were used as auxiliary substances in the granule technology. In laboratory conditions, granules based on phytoextracts were obtained by pressing wet masses. Numerical indicators of medicinal plant raw materials, technological properties of dry extracts and granules, as well as indicators of the quality of granules were determined according to the methods described in the State Pharmacopoeia XIV. Results and discussion. The numerical indicators of medicinal plant raw materials (grinding of raw materials and the content of impurities, total ash in medicinal plant materials and ash insoluble in hydrochloric acid, humidity, content of extractives) were determined and the good quality of the raw materials used in the subsequent stages of drug development was confirmed. Dry extracts from each type of medicinal plant raw materials have been developed and the technological properties of dry extracts have been determined. The composition and technology of effervescent granules by pressing wet masses has been developed. To improve the flowability and reduce the hygroscopicity of the granulated material, microcrystalline cellulose – 90 (EMCOCEL®90M) was used as a filler. To create an effervescent dosage form, citric acid and sodium bicarbonate were added to the granules. The mass for granulation was moistened with a 10% alcohol-water solution of Plasdone™ K-29/32. A draft specification of quality indicators for effervescent granules based on phytoextracts is proposed. Conclusion. In the course of the research work, the numerical indicators of medicinal plant raw materials were determined and its quality was confirmed, which made it possible to use it for further production of dry extracts. The extraction conditions were selected for each type of raw material, dry extracts were developed, and quality indicators were determined in accordance with the requirements of the State Pharmacopoeia XIV. Excipients were selected taking into account the properties of dry extracts, the composition and technology of effervescent granules based on phytoextracts was developed, a draft specification for effervescent granules was proposed in accordance with the requirements of the State Pharmacopoeia XIV." @default.
• W4200210965 created "2021-12-31" @default.
• W4200210965 creator A5016341656 @default.
• W4200210965 creator A5073997165 @default.
• W4200210965 creator A5076635886 @default.
• W4200210965 creator A5077564473 @default.
• W4200210965 date "2021-12-24" @default.
• W4200210965 modified "2023-10-16" @default.
• W4200210965 title "Development of Technology and Composition of the Medicinal Product for Oral Cavity Based on Phytosubstances" @default.
• W4200210965 cites W2297863531 @default.
• W4200210965 cites W2738826094 @default.
• W4200210965 cites W2888107416 @default.
• W4200210965 cites W2906934921 @default.
• W4200210965 cites W2978668530 @default.
• W4200210965 cites W2996603410 @default.
• W4200210965 cites W3017990117 @default.
• W4200210965 cites W3096532105 @default.
• W4200210965 cites W3117443684 @default.
• W4200210965 cites W3136833353 @default.
• W4200210965 cites W3165978880 @default.
• W4200210965 doi "https://doi.org/10.33380/2305-2066-2021-10-4(1)-37-45" @default.
• W4200210965 hasPublicationYear "2021" @default.
• W4200210965 type Work @default.
• W4200210965 citedByCount "1" @default.
• W4200210965 countsByYear W42002109652022 @default.
• W4200210965 crossrefType "journal-article" @default.
• W4200210965 hasAuthorship W4200210965A5016341656 @default.
• W4200210965 hasAuthorship W4200210965A5073997165 @default.
• W4200210965 hasAuthorship W4200210965A5076635886 @default.
• W4200210965 hasAuthorship W4200210965A5077564473 @default.
• W4200210965 hasBestOaLocation W42002109651 @default.
• W4200210965 hasConcept C159985019 @default.
• W4200210965 hasConcept C185592680 @default.
• W4200210965 hasConcept C192562407 @default.
• W4200210965 hasConcept C2779158651 @default.
• W4200210965 hasConcept C2779251873 @default.
• W4200210965 hasConcept C2779351475 @default.
• W4200210965 hasConcept C2991655182 @default.
• W4200210965 hasConcept C55493867 @default.
• W4200210965 hasConcept C556039675 @default.
• W4200210965 hasConcept C71924100 @default.
• W4200210965 hasConcept C88463166 @default.
• W4200210965 hasConcept C98274493 @default.
• W4200210965 hasConceptScore W4200210965C159985019 @default.
• W4200210965 hasConceptScore W4200210965C185592680 @default.
• W4200210965 hasConceptScore W4200210965C192562407 @default.
• W4200210965 hasConceptScore W4200210965C2779158651 @default.
• W4200210965 hasConceptScore W4200210965C2779251873 @default.
• W4200210965 hasConceptScore W4200210965C2779351475 @default.
• W4200210965 hasConceptScore W4200210965C2991655182 @default.
• W4200210965 hasConceptScore W4200210965C55493867 @default.
• W4200210965 hasConceptScore W4200210965C556039675 @default.
• W4200210965 hasConceptScore W4200210965C71924100 @default.
• W4200210965 hasConceptScore W4200210965C88463166 @default.
• W4200210965 hasConceptScore W4200210965C98274493 @default.
• W4200210965 hasIssue "4" @default.
• W4200210965 hasLocation W42002109651 @default.
• W4200210965 hasLocation W42002109652 @default.
• W4200210965 hasOpenAccess W4200210965 @default.
• W4200210965 hasPrimaryLocation W42002109651 @default.
• W4200210965 hasRelatedWork W1983279022 @default.
• W4200210965 hasRelatedWork W2095131275 @default.
• W4200210965 hasRelatedWork W2212364297 @default.
• W4200210965 hasRelatedWork W2379474612 @default.
• W4200210965 hasRelatedWork W2383408506 @default.
• W4200210965 hasRelatedWork W3016351020 @default.
• W4200210965 hasRelatedWork W3142581731 @default.
• W4200210965 hasRelatedWork W3144990614 @default.
• W4200210965 hasRelatedWork W4200210965 @default.
• W4200210965 hasRelatedWork W1504590079 @default.
• W4200210965 hasVolume "10" @default.
• W4200210965 isParatext "false" @default.
• W4200210965 isRetracted "false" @default.
• W4200210965 workType "article" @default.